These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26830300)

  • 1. White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink.
    Glanz JM; Newcomer SR; Jackson ML; Omer SB; Bednarczyk RA; Shoup JA; DeStefano F; Daley MF
    Vaccine; 2016 Feb; 34 Suppl 1():A1-A29. PubMed ID: 26830300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule.
    Daley MF; Glanz JM; Newcomer SR; Jackson ML; Groom HC; Lugg MM; McLean HQ; Klein NP; Weintraub ES; McNeil MM
    Vaccine; 2017 Apr; 35(15):1873-1878. PubMed ID: 28285983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of childhood immunization and all-cause mortality.
    McCarthy NL; Sukumaran L; Newcomer S; Glanz J; Daley MF; McClure D; Klein NP; Irving S; Jackson ML; Lewin B; Weintraub E
    Vaccine; 2017 Dec; 35(48 Pt B):6643-6648. PubMed ID: 29061349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing Potential Confounding and Misclassification Bias When Studying the Safety of the Childhood Immunization Schedule.
    Daley MF; Shoup JA; Newcomer SR; Jackson ML; Groom HC; Jacobsen SJ; McLean HQ; Klein NP; Weintraub ES; McNeil MM; Glanz JM
    Acad Pediatr; 2018; 18(7):754-762. PubMed ID: 29604461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
    LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
    Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Vaccine Safety Datalink: a model for monitoring immunization safety.
    Baggs J; Gee J; Lewis E; Fowler G; Benson P; Lieu T; Naleway A; Klein NP; Baxter R; Belongia E; Glanz J; Hambidge SJ; Jacobsen SJ; Jackson L; Nordin J; Weintraub E
    Pediatrics; 2011 May; 127 Suppl 1():S45-53. PubMed ID: 21502240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Vaccine Safety Datalink project.
    DeStefano F;
    Pharmacoepidemiol Drug Saf; 2001; 10(5):403-6. PubMed ID: 11802585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety.
    McNeil MM; Gee J; Weintraub ES; Belongia EA; Lee GM; Glanz JM; Nordin JD; Klein NP; Baxter R; Naleway AL; Jackson LA; Omer SB; Jacobsen SJ; DeStefano F
    Vaccine; 2014 Sep; 32(42):5390-8. PubMed ID: 25108215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety monitoring in vaccine development and immunization.
    Lee CJ; Lee LH; Lu CH; Huang YJ; Chu ML
    Acta Paediatr Taiwan; 2006; 47(1):7-13. PubMed ID: 17016963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians.
    Posfay-Barbe KM; Heininger U; Aebi C; Desgrandchamps D; Vaudaux B; Siegrist CA
    Pediatrics; 2005 Nov; 116(5):e623-33. PubMed ID: 16263976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children.
    Glanz JM; Newcomer SR; Daley MF; McClure DL; Baxter RP; Jackson ML; Naleway AL; Lugg MM; DeStefano F
    Vaccine; 2015 Nov; 33(48):6736-44. PubMed ID: 26518400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bias from outcome misclassification in immunization schedule safety research.
    Newcomer SR; Kulldorff M; Xu S; Daley MF; Fireman B; Lewis E; Glanz JM
    Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):221-228. PubMed ID: 29292551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA.
    Chen RT; DeStefano F; Davis RL; Jackson LA; Thompson RS; Mullooly JP; Black SB; Shinefield HR; Vadheim CM; Ward JI; Marcy SM
    Bull World Health Organ; 2000; 78(2):186-94. PubMed ID: 10743283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink.
    Naleway AL; Gold R; Kurosky S; Riedlinger K; Henninger ML; Nordin JD; Kharbanda EO; Irving S; Cheetham TC; McCarthy NL
    Vaccine; 2013 Jun; 31(27):2898-903. PubMed ID: 23639917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and Prevention.
    Moro PL; Haber P; McNeil MM
    Expert Rev Vaccines; 2019 Oct; 18(10):1091-1101. PubMed ID: 31580725
    [No Abstract]   [Full Text] [Related]  

  • 18. Parental vaccine safety concerns: results from the National Immunization Survey, 2001-2002.
    Allred NJ; Shaw KM; Santibanez TA; Rickert DL; Santoli JM
    Am J Prev Med; 2005 Feb; 28(2):221-4. PubMed ID: 15710279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommended childhood immunization schedule--United States, 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Jan; 49(2):35-8, 47. PubMed ID: 10680603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
    Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
    MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.